NYU Langone Hospital - Long Island, Mineola
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
y 1 más

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT03816345

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

Stony Brook University, Stony Brook

ReclutandoFase 2

Edades de 18 a 80 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07415044

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

Digestive Disease Medicine of Central New York, Utica

ReclutandoFase 2

Edades de 18 a 80 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07186101

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Icahn School of Medicine at Mount Sinai, New York

ReclutandoFase 3

Edades de 2 a 19 · Todos los sexos · Actualizado el 22 sept 2026 · NCT04844606

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

NYU Langone Health, New York
Weill Cornell Medical College- New York Presbyterian Hospital, New York

ReclutandoFase 4

Edades de 18 a 65 · Todos los sexos · Actualizado el 21 sept 2026 · NCT06095128

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

MedTraits NY - Site Number: 8400045, Maspeth
Weill Cornell Medicine - NewYork-Presbyterian Hospital - Site Number: 8400040, New York
New York Gastroenterology Associates - Site Number: 8400009, New York

ReclutandoFase 3

Edades de 16 a 80 · Todos los sexos · Actualizado el 15 sept 2026 · NCT07185009

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Westchester Putnam Gastroenterology PC, Carmel
Five Towns Gastroenterology, Cedarhurst
IMIDeology, Elmhurst
y 5 más

ReclutandoFase 4

Edades de 18 a 80 · Todos los sexos · Actualizado el 15 sept 2026 · NCT06581328

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

New York Gastroenterology Associates ( Site 0253), New York

ReclutandoFase 3

Todas las edades · Todos los sexos · Actualizado el 9 sept 2026 · NCT06651281

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

New York Gastroenterology Associates, New York

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 ago 2026 · NCT07577856

A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis

Fink Children's Ambulatory Care Center, New York
Kimmel Pavilion - NYU Langone, New York
NYU Grossman School of Medicine, New York
y 4 más

ReclutandoFase 2

Edades de 2 a 11 · Todos los sexos · Actualizado el 24 ago 2026 · NCT07470879

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

Columbia University Medical Center, New York

ReclutandoFase 2

Edades de 18 a 80 · Todos los sexos · Actualizado el 21 ago 2026 · NCT06636656

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

MedTraits NY - Site Number: 8400045, Maspeth
Manhattan Clinical Research, LLC - Site Number: 8400069, New York
NYU Langone Health - Site Number: 8400091, New York
y 4 más

ReclutandoFase 3

Edades de 16 a 80 · Todos los sexos · Actualizado el 20 ago 2026 · NCT07184996

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Saratoga Schenectady Gastroenterology Associates, Burnt Hills
NYU Langone Health, New York
Cornell University, New York

Reclutando

Edades de 18 en adelante · Todos los sexos · Actualizado el 7 ago 2026 · NCT05230173

BOOM-IBD2 Pivotal Clinical Trial

Northwell Health North Shore University Hospital, Manhasset
Columbia University Irving Medical Center/New York Presbyterian Hospital, New York

Reclutando

Edades de 18 a 85 · Todos los sexos · Actualizado el 6 ago 2026 · NCT06571669

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

New York University, New York

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 ago 2026 · NCT07237516

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

Ellipsis Research Group, Brooklyn
Smart Medical Research - Jackson Heights, Jackson Heights
Pioneer Clinical Research NY, New York
y 1 más

ReclutandoFase 2

Edades de 18 a 75 · Todos los sexos · Actualizado el 30 jul 2026 · NCT06598943

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

NYU Langone Health, New York
Lenox Hill Hospital, Northwell Health, New York

ReclutandoEstudio observacional

Edades de 18 a 64 · Todos los sexos · Actualizado el 9 jul 2026 · NCT06398626

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

New York Presbyterian Hospital, New York

ReclutandoFase 3

Edades de 2 a 17 · Todos los sexos · Actualizado el 22 jun 2026 · NCT06405087

A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

Investigational Site Number: 8400021, New York
Investigational Site Number: 8400029, Queens Village

ReclutandoFase 2

Edades de 18 a 75 · Todos los sexos · Actualizado el 23 abr 2026 · NCT06975722

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Mirador Therapeutics Selected Site, New York
Mirador Therapeutics Selected Site, Rochester

ReclutandoFase 2

Edades de 18 a 80 · Todos los sexos · Actualizado el 12 mar 2026 · NCT07113522

Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)

State University of New York Upstate Medical University, Syracuse

Reclutando

Edades de 18 a 85 · Todos los sexos · Actualizado el 8 ene 2026 · NCT05987852

Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis

Bausch Health Site 006, The Bronx

ReclutandoFase 4

Edades de 5 a 17 · Todos los sexos · Actualizado el 16 sept 2025 · NCT04314375

Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

New York University, New York

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 8 may 2025 · NCT06750731

De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.